News
US biotech Lexeo Therapeutics has secured $80 million from a private placement, giving the company enough capital to push ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback